Hunting Hill Global Capital, LLC Essa Pharma Inc. Transaction History

Hunting Hill Global Capital, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$2.56 - $3.55 $25,600 - $35,500	-10,000 Reduced 50.0%	10,000 $29,000
Q4 2022 Feb 14, 2023	BUY	$1.5 - $4.82 $15,000 - $48,200	10,000 Added 100.0%	20,000 $50,000
Q3 2022 Nov 14, 2022	BUY	$1.75 - $3.44 $17,500 - $34,400	10,000 New	10,000 $18,000

35.1M

15.8K

21K

Ticker EPIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,073,100
Market Cap $79.8M
Description
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...

Get notified when there are updates to the investment portfolio of Hunting Hill Global Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Hunting Hill Global Capital, LLC with notifications on news.